Mostrar el registro sencillo del ítem

dc.contributor.authorWang, Xu
dc.contributor.authorAlmazan, Francisco
dc.contributor.authorMontoyo Pujol, Yoel Genaro
dc.contributor.authorMartin Casares, Antonia
dc.contributor.authorMartín, Aurelio
dc.contributor.authorCabrera Castillo, María Teresa 
dc.contributor.authorLópez Nevot, Miguel Ángel 
dc.date.accessioned2021-11-25T10:50:08Z
dc.date.available2021-11-25T10:50:08Z
dc.date.issued2021-09-30
dc.identifier.citationXu Wang, Francisco Almazan, Yoel Genaro Montoyo-Pujol, Antonia Martin-Casares, Aurelio Martin, Teresa Cabrera, Miguel Angel López-Nevot, "HLA-DRB116:01 and HLA-DQB105:02 Alleles Influence the Susceptibility and Progression of Cutaneous Malignant Melanoma", Journal of Oncology, vol. 2021, Article ID 3801143, 7 pages, 2021. [https://doi.org/10.1155/2021/3801143]es_ES
dc.identifier.urihttp://hdl.handle.net/10481/71752
dc.descriptionThe authors would like to thank Xiaodun Huo for his technical assistance. This work was supported by Instituto de Salud Carlos III (FISS PI 13/02119).es_ES
dc.description.abstractBackground. The influence of HLA class I and II loci on the susceptibility to melanoma remains an area of intense debate. This study aimed to examine whether the HLA system was related to melanoma susceptibility and prognosis in a southern Spanish population. Methods. In this study, HLA class I and class II genotyping were performed using polymerase chain reaction sequence-specific oligonucleotides (PCR-SSO) in 237 Spanish melanoma patients and 636 ethnically matched controls. Data were analyzed according to the clinical characteristics of the defined subgroups. Results. Compared to the control group, DRB1∗16:01 (4% vs. 1.3%, p=0.001, Pc = 0.035, OR = 3.28) and DQB1∗05:02 (4.9% vs. 2%, p=0.001, Pc = 0.017, OR = 2.54) were positivity associated with the susceptibility to melanoma. Both DRB1∗16:01 (5.4% vs. 1.3%, p=0.001, Pc = 0.035, OR = 4.46) and DQB1∗05:02 (6.5% vs. 2%, p=0.001, Pc = 0.017, OR = 3.44) also showed a positive correlation with Breslow thickness >1.5 mm, most notably at an early age of diagnosis (≤58 years), DRB1∗16:01 (4.2% vs. 1.3%, p=0.001, Pc = 0.035, OR = 3.41) and DQB1∗05:02 (5.4% vs. 2%, p=0.002, Pc = 0.034, OR = 2.86). Conclusion. These findings established HLA-DRB1∗16:01 and HLA-DQB1∗05:02 loci as melanoma risk factors in the southern Spanish population.es_ES
dc.description.sponsorshipInstituto de Salud Carlos III (FISS PI 13/02119)es_ES
dc.language.isoenges_ES
dc.publisherHindawi Limitedes_ES
dc.rightsAtribución 3.0 España*
dc.rights.urihttp://creativecommons.org/licenses/by/3.0/es/*
dc.titleHLA-DRB1 ∗ 16:01 and HLA-DQB1 ∗ 05:02 Alleles Influence the Susceptibility and Progression of Cutaneous Malignant Melanomaes_ES
dc.typejournal articlees_ES
dc.rights.accessRightsopen accesses_ES
dc.identifier.doi10.1155/2021/3801143
dc.type.hasVersionVoRes_ES


Ficheros en el ítem

[PDF]

Este ítem aparece en la(s) siguiente(s) colección(ones)

Mostrar el registro sencillo del ítem

Atribución 3.0 España
Excepto si se señala otra cosa, la licencia del ítem se describe como Atribución 3.0 España